Načítá se...
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
PURPOSE: Hepatocellular carcinoma (HCC) incidence rates have been increasing in the United States for the past 35 years. Because HCC has a poor prognosis, quantitative forecasts could help to inform prevention and treatment strategies to reduce the incidence and burden of HCC. METHODS: Single-year H...
Uloženo v:
| Vydáno v: | J Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966339/ https://ncbi.nlm.nih.gov/pubmed/27044939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.7412 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|